ReP USP - Resultado da busca

Artigo de periodico
Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? (2023)
Pimentel, Mariana Vieira de Mello Barros; Bertolami, Adriana; Fernandes, Lígia Prestes; Barroso, Lucia Pereira; Castro, Inar Alves de
Source: Biomedicine and Pharmacotherapy. Unidades: IDPC, IME, FCF
Subjects: BIOMARCADORES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros et al. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?. Biomedicine and Pharmacotherapy, v. 160, p. 1-12 art. 114345, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2023.114345. Acesso em: 28 maio 2024.
APA
Pimentel, M. V. de M. B., Bertolami, A., Fernandes, L. P., Barroso, L. P., & Castro, I. A. de. (2023). Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? Biomedicine and Pharmacotherapy, 160, 1-12 art. 114345. doi:10.1016/j.biopha.2023.114345
NLM
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345
Vancouver
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345
Artigo de periodico
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach (2023)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Silbiger, Vivian Nogueira ; Luchessi, Andre Ducati ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Molecular Biology Reports. Unidades: IDPC, FCF
Subjects: MICRORNAS, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, v. 50, n. 11, p. 9165-9177, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11033-023-08784-9. Acesso em: 28 maio 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Borges, J. B., Oliveira, V. F. de, Hernandez, C. D., Marçal, E. da S. R., et al. (2023). LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, 50( 11), 9165-9177. doi:10.1007/s11033-023-08784-9
NLM
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 maio 28 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Vancouver
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 maio 28 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Artigo de periodico
Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients (2022)
Nascimento, Larissa Vilela ; Lotufo Neto, Francisco ; Moreira, Dalmo Antonio Ribeiro ; Cerutti, Virginia Braga; Thurow, Helena Strelow ; Bastos, Gisele Medeiros ; Ferreira, Eric Batista ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: FM, IDPC, FCF
Subjects: METILAÇÃO DE DNA, ANTIDEPRESSIVOS, ARRITMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Larissa Vilela et al. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients. Epigenomics, v. 14, n. 14, p. 851-864, 2022Tradução . . Disponível em: https://doi.org/10.2217/epi-2022-0089. Acesso em: 28 maio 2024.
APA
Nascimento, L. V., Lotufo Neto, F., Moreira, D. A. R., Cerutti, V. B., Thurow, H. S., Bastos, G. M., et al. (2022). Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients. Epigenomics, 14( 14), 851-864. doi:10.2217/epi-2022-0089
NLM
Nascimento LV, Lotufo Neto F, Moreira DAR, Cerutti VB, Thurow HS, Bastos GM, Ferreira EB, Hirata RDC, Hirata MH. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients [Internet]. Epigenomics. 2022 ; 14( 14): 851-864.[citado 2024 maio 28 ] Available from: https://doi.org/10.2217/epi-2022-0089
Vancouver
Nascimento LV, Lotufo Neto F, Moreira DAR, Cerutti VB, Thurow HS, Bastos GM, Ferreira EB, Hirata RDC, Hirata MH. Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients [Internet]. Epigenomics. 2022 ; 14( 14): 851-864.[citado 2024 maio 28 ] Available from: https://doi.org/10.2217/epi-2022-0089
Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: IDPC, ICB, FCF
Subjects: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 28 maio 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 maio 28 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 maio 28 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass (2021)
Silva, Carlos Gustavo dos Santos ; Nigro Neto, Caetano ; Hirata, Mario Hiroyuki ; Tardelli, Maria Angela; Bastos, Gisele Medeiros ; França, Joao Italo Dias ; Cardoso, Thiago Augusto Azevedo Maranhão
Source: Journal of Cardiothoracic and Vascular Anesthesia. Unidades: IDPC, FCF, FSP
Subjects: REVASCULARIZAÇÃO MIOCÁRDICA, ANESTÉSICOS, CIRCULAÇÃO EXTRACORPÓREA, ANESTESIA GERAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carlos Gustavo dos Santos et al. Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, v. 35, n. 8, p. 2447-2453, 2021Tradução . . Disponível em: https://doi.org/10.1053/j.jvca.2020.12.032. Acesso em: 28 maio 2024.
APA
Silva, C. G. dos S., Nigro Neto, C., Hirata, M. H., Tardelli, M. A., Bastos, G. M., França, J. I. D., & Cardoso, T. A. A. M. (2021). Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, 35( 8), 2447-2453. doi:10.1053/j.jvca.2020.12.032
NLM
Silva CG dos S, Nigro Neto C, Hirata MH, Tardelli MA, Bastos GM, França JID, Cardoso TAAM. Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass [Internet]. Journal of Cardiothoracic and Vascular Anesthesia. 2021 ; 35( 8): 2447-2453.[citado 2024 maio 28 ] Available from: https://doi.org/10.1053/j.jvca.2020.12.032
Vancouver
Silva CG dos S, Nigro Neto C, Hirata MH, Tardelli MA, Bastos GM, França JID, Cardoso TAAM. Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass [Internet]. Journal of Cardiothoracic and Vascular Anesthesia. 2021 ; 35( 8): 2447-2453.[citado 2024 maio 28 ] Available from: https://doi.org/10.1053/j.jvca.2020.12.032
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Subjects: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 28 maio 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report (2021)
Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Marçal, Elisangela da Silva Rodrigues; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Borges, Jéssica Bassani ; Bastos, Gisele Medeiros ; Los, Bruna; Mori, Augusto Akira ; Bortolin, Raul Hernandes ; Ferreira, Glaucio Monteiro ; Oliveira, Victor Fernandes de ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Annals of Translational Medicine. Unidades: IDPC, FCF
Subjects: HIPERCOLESTEROLEMIA, ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, v. 9, n. 1, p. 1-8 art. 76, 2021Tradução . . Disponível em: https://doi.org/10.21037/atm-20-5540. Acesso em: 28 maio 2024.
APA
Hernandez, C. D., Freitas, R. C. C. de, Marçal, E. da S. R., Gonçalves, R. M., Faludi, A. A., Borges, J. B., et al. (2021). Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, 9( 1), 1-8 art. 76. doi:10.21037/atm-20-5540
NLM
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 maio 28 ] Available from: https://doi.org/10.21037/atm-20-5540
Vancouver
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 maio 28 ] Available from: https://doi.org/10.21037/atm-20-5540
Artigo de periodico
Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial (2021)
Cardoso, Thiago Augusto Azevedo Maranhão ; Kunst, Gudrun; Nigro Neto, Caetano; Costa Junior, José de Ribamar; Silva, Carlos Gustavo Santos; Bastos, Gisele Medeiros ; Borges, Jéssica Bassani ; Hirata, Mario Hiroyuki
Source: Trials. Unidades: IDPC, FCF
Subjects: CIRURGIA TORÁCICA, ÉTER, ANESTÉSICOS, CIRCULAÇÃO EXTRACORPÓREA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Thiago Augusto Azevedo Maranhão et al. Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial. Trials, v. 22, p. 1-10 art. 25, 2021Tradução . . Disponível em: https://doi.org/10.1186/s13063-020-04809-x. Acesso em: 28 maio 2024.
APA
Cardoso, T. A. A. M., Kunst, G., Nigro Neto, C., Costa Junior, J. de R., Silva, C. G. S., Bastos, G. M., et al. (2021). Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial. Trials, 22, 1-10 art. 25. doi:10.1186/s13063-020-04809-x
NLM
Cardoso TAAM, Kunst G, Nigro Neto C, Costa Junior J de R, Silva CGS, Bastos GM, Borges JB, Hirata MH. Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial [Internet]. Trials. 2021 ; 22 1-10 art. 25.[citado 2024 maio 28 ] Available from: https://doi.org/10.1186/s13063-020-04809-x
Vancouver
Cardoso TAAM, Kunst G, Nigro Neto C, Costa Junior J de R, Silva CGS, Bastos GM, Borges JB, Hirata MH. Effect of sevoflurane on the inflammatory response during cardiopulmonary bypass in cardiac surgery: the study protocol for a randomized controlled trial [Internet]. Trials. 2021 ; 22 1-10 art. 25.[citado 2024 maio 28 ] Available from: https://doi.org/10.1186/s13063-020-04809-x
Artigo de periodico
Pulmonary vascular volume estimated by automated software is a mortality predictor after acute pulmonary embolism (2020)
Soriano, Leonardo; Santos, Marcel Koenigkam ; Wada, Danilo Tadao ; Vilalva, Kelvin ; Castro, Talita Tavares ; Weinheimer, Oliver; Muglia, Valdair Francisco ; Pazin Filho, Antônio ; Miranda, Carlos Henrique
Source: Arquivos Brasileiros de Cardiologia. Unidades: FMRP, CENA, IDPC
Subjects: DOENÇA AGUDA, ANGIOGRAFIA, ARTÉRIA PULMONAR, DIAGNÓSTICO POR IMAGEM, EMBOLIA PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORIANO, Leonardo et al. Pulmonary vascular volume estimated by automated software is a mortality predictor after acute pulmonary embolism. Arquivos Brasileiros de Cardiologia, v. 115, n. 5, p. 809-818, 2020Tradução . . Disponível em: https://doi.org/10.36660/abc.20190392. Acesso em: 28 maio 2024.
APA
Soriano, L., Santos, M. K., Wada, D. T., Vilalva, K., Castro, T. T., Weinheimer, O., et al. (2020). Pulmonary vascular volume estimated by automated software is a mortality predictor after acute pulmonary embolism. Arquivos Brasileiros de Cardiologia, 115( 5), 809-818. doi:10.36660/abc.20190392
NLM
Soriano L, Santos MK, Wada DT, Vilalva K, Castro TT, Weinheimer O, Muglia VF, Pazin Filho A, Miranda CH. Pulmonary vascular volume estimated by automated software is a mortality predictor after acute pulmonary embolism [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 115( 5): 809-818.[citado 2024 maio 28 ] Available from: https://doi.org/10.36660/abc.20190392
Vancouver
Soriano L, Santos MK, Wada DT, Vilalva K, Castro TT, Weinheimer O, Muglia VF, Pazin Filho A, Miranda CH. Pulmonary vascular volume estimated by automated software is a mortality predictor after acute pulmonary embolism [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 115( 5): 809-818.[citado 2024 maio 28 ] Available from: https://doi.org/10.36660/abc.20190392
Artigo de periodico
Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil (2019)
Soriano, Leonardo de Araújo ; Castro, Talita Tavares ; Vilalva, Kelvin ; Borges, Marcos de Carvalho ; Pazin Filho, Antônio ; Miranda, Carlos Henrique
Source: Jornal Brasileiro de Pneumologia. Unidades: FMRP, IDPC
Subjects: EMBOLIA PULMONAR, ÍNDICE DE GRAVIDADE DA DOENÇA, AVALIAÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORIANO, Leonardo de Araújo et al. Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil. Jornal Brasileiro de Pneumologia, v. 45, n. 1, p. [7] , 2019Tradução . . Disponível em: https://doi.org/10.1590/1806-3713/e20170251. Acesso em: 28 maio 2024.
APA
Soriano, L. de A., Castro, T. T., Vilalva, K., Borges, M. de C., Pazin Filho, A., & Miranda, C. H. (2019). Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil. Jornal Brasileiro de Pneumologia, 45( 1), [7] . doi:10.1590/1806-3713/e20170251
NLM
Soriano L de A, Castro TT, Vilalva K, Borges M de C, Pazin Filho A, Miranda CH. Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil [Internet]. Jornal Brasileiro de Pneumologia. 2019 ; 45( 1): [7] .[citado 2024 maio 28 ] Available from: https://doi.org/10.1590/1806-3713/e20170251
Vancouver
Soriano L de A, Castro TT, Vilalva K, Borges M de C, Pazin Filho A, Miranda CH. Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil [Internet]. Jornal Brasileiro de Pneumologia. 2019 ; 45( 1): [7] .[citado 2024 maio 28 ] Available from: https://doi.org/10.1590/1806-3713/e20170251
Artigo de periodico
In Vitro hydrodynamic evaluation of a scaffold for heart valve tissue engineering (2019)
Bazan, Ovandir ; Simbara, Márcia M O ; Ortiz, Jayme Pinto ; Malmomge, Sonia M ; Andrade, Aron José Pazin de; Yanagihara, Jurandir Itizo
Source: Artificial Organs. Unidades: EP, IDPC
Subjects: VALVAS CARDÍACAS, HIDRODINÂMICA, ENGENHARIA TECIDUAL, VALVA MITRAL, BIOPRÓTESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAZAN, Ovandir et al. In Vitro hydrodynamic evaluation of a scaffold for heart valve tissue engineering. Artificial Organs, v. 43, n. 2, p. 195-198, 2019Tradução . . Disponível em: https://doi.org/10.1111/aor.12515. Acesso em: 28 maio 2024.
APA
Bazan, O., Simbara, M. M. O., Ortiz, J. P., Malmomge, S. M., Andrade, A. J. P. de, & Yanagihara, J. I. (2019). In Vitro hydrodynamic evaluation of a scaffold for heart valve tissue engineering. Artificial Organs, 43( 2), 195-198. doi:10.1111/aor.12515
NLM
Bazan O, Simbara MMO, Ortiz JP, Malmomge SM, Andrade AJP de, Yanagihara JI. In Vitro hydrodynamic evaluation of a scaffold for heart valve tissue engineering [Internet]. Artificial Organs. 2019 ; 43( 2): 195-198.[citado 2024 maio 28 ] Available from: https://doi.org/10.1111/aor.12515
Vancouver
Bazan O, Simbara MMO, Ortiz JP, Malmomge SM, Andrade AJP de, Yanagihara JI. In Vitro hydrodynamic evaluation of a scaffold for heart valve tissue engineering [Internet]. Artificial Organs. 2019 ; 43( 2): 195-198.[citado 2024 maio 28 ] Available from: https://doi.org/10.1111/aor.12515
Artigo de periodico
Development of a transventricular assist Device (TVAD): influence of the volute vanes (2018)
Andrade, Gustavo Caravita de; Andrade, Aron José Pazin de; Fonseca, Jeison William Gomes da; Silva, Bruno Utiyama; Drigo, Evandro ; Cardoso, José Roberto ; Horikawa, Oswaldo
Source: IFAC-PapersOnLine. Unidades: IDPC, EP
Subjects: VENTRÍCULO CARDÍACO, DINÂMICA DOS FLUÍDOS COMPUTACIONAL, DINÂMICA DOS FLUÍDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Gustavo Caravita de et al. Development of a transventricular assist Device (TVAD): influence of the volute vanes. IFAC-PapersOnLine, v. 51, n. 29, p. 158-161, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ifacol.2018.11.650. Acesso em: 28 maio 2024.
APA
Andrade, G. C. de, Andrade, A. J. P. de, Fonseca, J. W. G. da, Silva, B. U., Drigo, E., Cardoso, J. R., & Horikawa, O. (2018). Development of a transventricular assist Device (TVAD): influence of the volute vanes. IFAC-PapersOnLine, 51( 29), 158-161. doi:10.1016/j.ifacol.2018.11.650
NLM
Andrade GC de, Andrade AJP de, Fonseca JWG da, Silva BU, Drigo E, Cardoso JR, Horikawa O. Development of a transventricular assist Device (TVAD): influence of the volute vanes [Internet]. IFAC-PapersOnLine. 2018 ; 51( 29): 158-161.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/j.ifacol.2018.11.650
Vancouver
Andrade GC de, Andrade AJP de, Fonseca JWG da, Silva BU, Drigo E, Cardoso JR, Horikawa O. Development of a transventricular assist Device (TVAD): influence of the volute vanes [Internet]. IFAC-PapersOnLine. 2018 ; 51( 29): 158-161.[citado 2024 maio 28 ] Available from: https://doi.org/10.1016/j.ifacol.2018.11.650
Trabalho de evento
Supervisory control system associated with the development of device thrombosis in VAD (2018)
Souza Sobrinho, Jose Ricardo; Legaspe, Edinei Peres; Drigo, Evandro ; Dias, Jônatas Cerqueira ; Dias, Jeferson Carlos; Barboza, Marcelo; Miyagi, Paulo Eigi ; Okamoto Junior, Jun ; Junqueira, Fabrício ; Bock, Eduardo Guy Perpetuo ; Santos Filho, Diolino Jose dos
Source: Technological Innovation for the internet of things: Proceedings. Conference titles: IFIP WG 5.5/SOCOLNET Advanced Doctoral Conference on Computing, Electrical and Industrial Systems, DoCEIS 2018. Unidades: EP, STI, IDPC
Subjects: VENTRÍCULO CARDÍACO, SISTEMAS DE CONTROLE, TROMBOSE, VIBRAÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA SOBRINHO, Jose Ricardo et al. Supervisory control system associated with the development of device thrombosis in VAD. 2018, Anais.. s.L.: Springer Verlag, 2018. Disponível em: https://doi.org/10.1007/978-3-319-78574-5_9. Acesso em: 28 maio 2024.
APA
Souza Sobrinho, J. R., Legaspe, E. P., Drigo, E., Dias, J. C., Dias, J. C., Barboza, M., et al. (2018). Supervisory control system associated with the development of device thrombosis in VAD. In Technological Innovation for the internet of things: Proceedings. s.L.: Springer Verlag. doi:10.1007/978-3-319-78574-5_9
NLM
Souza Sobrinho JR, Legaspe EP, Drigo E, Dias JC, Dias JC, Barboza M, Miyagi PE, Okamoto Junior J, Junqueira F, Bock EGP, Santos Filho DJ dos. Supervisory control system associated with the development of device thrombosis in VAD [Internet]. Technological Innovation for the internet of things: Proceedings. 2018 ;[citado 2024 maio 28 ] Available from: https://doi.org/10.1007/978-3-319-78574-5_9
Vancouver
Souza Sobrinho JR, Legaspe EP, Drigo E, Dias JC, Dias JC, Barboza M, Miyagi PE, Okamoto Junior J, Junqueira F, Bock EGP, Santos Filho DJ dos. Supervisory control system associated with the development of device thrombosis in VAD [Internet]. Technological Innovation for the internet of things: Proceedings. 2018 ;[citado 2024 maio 28 ] Available from: https://doi.org/10.1007/978-3-319-78574-5_9

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation